Diebold Nixdorf, Incorporated
DBD
$71.66
-$3.72-4.94%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 930.80M | 891.80M | 1.10B | 945.20M | 915.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 930.80M | 891.80M | 1.10B | 945.20M | 915.20M |
| Cost of Revenue | 686.10M | 666.60M | 804.50M | 697.30M | 672.50M |
| Gross Profit | 244.70M | 225.20M | 299.70M | 247.90M | 242.70M |
| SG&A Expenses | 147.80M | 145.30M | 151.10M | 141.00M | 147.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -600.00K | 1.10M | -200.00K | 100.00K | 100.00K |
| Total Operating Expenses | 853.80M | 835.10M | 976.40M | 858.80M | 842.70M |
| Operating Income | 77.00M | 56.70M | 127.80M | 86.40M | 72.50M |
| Income Before Tax | 35.40M | 11.20M | 62.40M | 51.30M | 17.50M |
| Income Tax Expenses | 19.20M | 5.70M | 11.90M | 9.60M | 4.80M |
| Earnings from Continuing Operations | 16.20M | 5.50M | 50.50M | 41.70M | 12.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -700.00K | -500.00K | -900.00K | -600.00K | -500.00K |
| Net Income | 15.50M | 5.00M | 49.60M | 41.10M | 12.20M |
| EBIT | 77.00M | 56.70M | 127.80M | 86.40M | 72.50M |
| EBITDA | 107.80M | 88.10M | 147.20M | 118.10M | 103.70M |
| EPS Basic | 0.45 | 0.14 | 1.39 | 1.13 | 0.33 |
| Normalized Basic EPS | 0.98 | 0.61 | 1.86 | 1.08 | 0.55 |
| EPS Diluted | 0.44 | 0.14 | 1.36 | 1.11 | 0.33 |
| Normalized Diluted EPS | 0.95 | 0.60 | 1.83 | 1.06 | 0.55 |
| Average Basic Shares Outstanding | 34.40M | 35.10M | 35.80M | 36.50M | 37.20M |
| Average Diluted Shares Outstanding | 35.30M | 35.70M | 36.30M | 37.00M | 37.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |